Literature DB >> 22789864

Expression of apoptosis-related genes in the endometrium of polycystic ovary syndrome patients during the window of implantation.

Ling Yan1, Aiming Wang, Lei Chen, Wei Shang, Min Li, Yong Zhao.   

Abstract

The present study investigated the expression of the apoptosis-related genes fas-associated via death domain (FADD) and Bcl-2 in the endometrium during the window of implantation in polycystic ovary syndrome (PCOS) patients. The aim was to explore the role of cell apoptosis in endometrial receptivity during this period. The subjects were divided into experimental and control group. The experimental group comprised 12 infertile women with PCOS, and the control group comprised 12 women who were infertile because of tubal pathological factors but had normal menstrual cycles. Endometria were collected by biopsy 7d after ovulation. Six samples from each group were randomly selected and subjected to gene chip analyses. The expression of endometrial FADD and Bcl-2 was determined by immunohistochemistry, and cell apoptosis was detected by the TUNEL method. Compared with the control group, 194 differentially expressed genes were found in the PCOS group, 102 of which were upregulated and 92 were downregulated. The differentially expressed genes were divided into 15 types according to function. Among the nine genes related to cell apoptosis, five (including Bcl-2) were upregulated and four were downregulated (including FADD). Bcl-2 expression during the window of implantation in the PCOS group increased compared with the control group, showing a significant difference (P<0.05). FADD expression in the PCOS group notably decreased compared with that in the control group, which also showed a significant difference (P<0.05). Cell apoptosis analysis showed a significant difference between the average apoptotic indices in the PCOS and control groups (P<0.05). Significant differences were observed between the endometrial gene expression in the PCOS and control groups. The decrease in cell apoptosis during the window of implantation in PCOS patients may be one of the causes of the reduced endometrial receptivity.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22789864     DOI: 10.1016/j.gene.2012.06.037

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity.

Authors:  D Abdulkhalikova; A Sustarsic; Eda Vrtačnik Bokal; N Jancar; M Jensterle; T Burnik Papler
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

2.  A Systematic Review and Integrated Bioinformatic Analysis of Candidate Genes and Pathways in the Endometrium of Patients With Polycystic Ovary Syndrome During the Implantation Window.

Authors:  Zulazmi Sutaji; Marjanu Hikmah Elias; Mohd Faizal Ahmad; Abdul Kadir Abdul Karim; Muhammad Azrai Abu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-01       Impact factor: 6.055

3.  Genome-wide Association Studies for Female Fertility Traits in Chinese and Nordic Holsteins.

Authors:  Aoxing Liu; Yachun Wang; Goutam Sahana; Qin Zhang; Lin Liu; Mogens Sandø Lund; Guosheng Su
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

4.  Genetic loci associated with coronary artery disease harbor evidence of selection and antagonistic pleiotropy.

Authors:  Sean G Byars; Qin Qin Huang; Lesley-Ann Gray; Andrew Bakshi; Samuli Ripatti; Gad Abraham; Stephen C Stearns; Michael Inouye
Journal:  PLoS Genet       Date:  2017-06-22       Impact factor: 5.917

Review 5.  An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome.

Authors:  Jinyan Zhao; Qing Chen; Xiang Xue
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

Review 6.  Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.

Authors:  Ahmad J H Albaghdadi; Frederick W K Kan
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.